Providing medication alternatives during intranasal desmopressin recall-Reference-Cited by-同舟云学术

Providing medication alternatives during intranasal desmopressin recall

Published:2021-10-04 Issue:1 Volume:28 Page:190-193
ISSN:1078-1552
Container-title:Journal of Oncology Pharmacy Practice
language:en
Short-container-title:J Oncol Pharm Pract

Author:

Koon Alexis¹^ORCID,Perciavalle Kristin²,Oleis Johnna²,Arnall Justin³

Affiliation:

1. Department of Pharmacy, Atrium Health Carolinas Medical Center, USA

2. Vanderbilt Specialty Pharmacy Services, Vanderbilt University Medical Center, USA

3. Atrium Health Specialty Pharmacy Service, Atrium Health Carolinas Medical Center, USA

Publisher

SAGE Publications

Subject

Pharmacology (medical),Oncology

Link

http://journals.sagepub.com/doi/pdf/10.1177/10781552211037860

Reference17 articles.

1. Desmopressin. In: UpToDate [database on the Internet]. Waltham (MA): UpToDate, Inc.; 2020 [updated 2020, cited 2020 Dec 21].

2. Assessment and validation of a defined fluid restriction protocol in the use of subcutaneous desmopressin for children with inherited bleeding disorders

3. Center for Drug Evaluation and Research. Ferring US Issues Voluntary Nationwide Recall of DDAVP® Nasal Spray 10 mcg/0.1 mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1 mL, STIMATE® Nasal Spray 1.5 mg/mL Due to Superpotency. U.S. Food and Drug Administration. https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/ferring-us-issues-voluntary-nationwide-recall-ddavpr-nasal-spray-10-mcg01ml-desmopressin-acetate. (Accessed December 28, 2020).

4. Stimate Recall Update. National Hemophilia Foundation. https://www.hemophilia.org/news/stimate-recall-update. (Accessed December 28, 2020).

5. Peri A. Morbidity and Mortality of Hyponatremia. Front Horm Res. 2019;52:36–48. doi: 10.1159/000493235. Epub 2019 Jan 15. PMID: 32097927.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Moderate-intensity aerobic exercise vs desmopressin in adolescent males with mild hemophilia A: a randomized trial;Blood;2022-09-08